| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 3.84e-06 | 103 | 46 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 7.21e-05 | 189 | 46 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.45e-04 | 386 | 46 | 6 | GO:0042578 | |
| GeneOntologyMolecularFunction | hydro-lyase activity | 4.12e-04 | 63 | 46 | 3 | GO:0016836 | |
| GeneOntologyMolecularFunction | phosphatase activity | 5.01e-04 | 287 | 46 | 5 | GO:0016791 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.91e-04 | 17 | 46 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.91e-04 | 17 | 46 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | carbon-oxygen lyase activity | 8.92e-04 | 82 | 46 | 3 | GO:0016835 | |
| GeneOntologyMolecularFunction | lyase activity | 1.42e-03 | 212 | 46 | 4 | GO:0016829 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.40e-03 | 599 | 46 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.03e-03 | 431 | 46 | 5 | GO:0004984 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 3.30e-03 | 1353 | 46 | 9 | GO:0004888 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.10e-04 | 384 | 47 | 6 | GO:0030139 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.50e-08 | 39 | 45 | 5 | PS50055 | |
| Domain | PTPase_domain | 4.54e-08 | 41 | 45 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 4.54e-08 | 41 | 45 | 5 | PF00102 | |
| Domain | PTPc_motif | 2.93e-07 | 59 | 45 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.93e-07 | 59 | 45 | 5 | IPR003595 | |
| Domain | TYR_PHOSPHATASE_1 | 1.95e-06 | 86 | 45 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 2.06e-06 | 87 | 45 | 5 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 2.06e-06 | 87 | 45 | 5 | IPR000387 | |
| Domain | - | 2.72e-06 | 92 | 45 | 5 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.90e-06 | 99 | 45 | 5 | IPR029021 | |
| Domain | - | 3.40e-05 | 4 | 45 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 3.40e-05 | 4 | 45 | 2 | IPR004212 | |
| Domain | GTF2I | 3.40e-05 | 4 | 45 | 2 | PS51139 | |
| Domain | GTF2I | 3.40e-05 | 4 | 45 | 2 | PF02946 | |
| Domain | PTPc | 8.83e-05 | 36 | 45 | 3 | SM00194 | |
| Domain | Tyr_Pase_AS | 7.23e-04 | 73 | 45 | 3 | IPR016130 | |
| Domain | Ig_I-set | 1.12e-03 | 190 | 45 | 4 | IPR013098 | |
| Domain | I-set | 1.12e-03 | 190 | 45 | 4 | PF07679 | |
| Domain | IGc2 | 2.43e-03 | 235 | 45 | 4 | SM00408 | |
| Domain | Ig_sub2 | 2.43e-03 | 235 | 45 | 4 | IPR003598 | |
| Domain | Dual-sp_phosphatase_cat-dom | 4.38e-03 | 41 | 45 | 2 | IPR000340 | |
| Domain | DSPc | 4.38e-03 | 41 | 45 | 2 | PF00782 | |
| Domain | fn3 | 6.96e-03 | 162 | 45 | 3 | PF00041 | |
| Domain | FN3 | 1.00e-02 | 185 | 45 | 3 | SM00060 | |
| Domain | ig | 1.07e-02 | 190 | 45 | 3 | PF00047 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.55e-05 | 20 | 35 | 3 | M27290 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.55e-05 | 20 | 35 | 3 | MM15485 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.55e-05 | 20 | 35 | 3 | MM14991 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.81e-05 | 21 | 35 | 3 | M27736 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 2.85e-12 | 12 | 47 | 5 | 12906860 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.31e-09 | 3 | 47 | 3 | 31985401 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 20139422 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.31e-09 | 3 | 47 | 3 | 33656439 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 8524829 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 22357843 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10777529 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 19273906 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 29073098 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 12376545 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 28637841 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 37591863 | ||
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 25624497 | ||
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 7832766 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 5.05e-07 | 12 | 47 | 3 | 9624153 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.55e-06 | 17 | 47 | 3 | 19727691 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7665159 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 9566880 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.79e-06 | 2 | 47 | 2 | 15388857 | |
| Pubmed | PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. | 1.79e-06 | 2 | 47 | 2 | 12782572 | |
| Pubmed | Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma. | 1.79e-06 | 2 | 47 | 2 | 18684031 | |
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 5.36e-06 | 3 | 47 | 2 | 25394468 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 15100712 | ||
| Pubmed | Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. | 5.36e-06 | 3 | 47 | 2 | 9514946 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16832410 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17440740 | ||
| Pubmed | Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. | 5.36e-06 | 3 | 47 | 2 | 12516958 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 9633825 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 23555575 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25703008 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22413991 | ||
| Pubmed | 5.88e-06 | 26 | 47 | 3 | 36178190 | ||
| Pubmed | 9.70e-06 | 1049 | 47 | 9 | 27880917 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 26231120 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 14967925 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23362275 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 24632616 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 21328569 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17823943 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 23229069 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 12235145 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 22899722 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 10747914 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 38388459 | ||
| Pubmed | Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. | 2.67e-05 | 6 | 47 | 2 | 16738228 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 2.67e-05 | 6 | 47 | 2 | 21126580 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 23345436 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 1454056 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 4.39e-05 | 974 | 47 | 8 | 28675297 | |
| Pubmed | NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. | 4.98e-05 | 8 | 47 | 2 | 22406547 | |
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 31875546 | ||
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 22902294 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.18e-04 | 573 | 47 | 6 | 28330616 | |
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 23863482 | ||
| Pubmed | 2.04e-04 | 84 | 47 | 3 | 31616248 | ||
| Pubmed | 2.12e-04 | 16 | 47 | 2 | 11564885 | ||
| Pubmed | CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. | 2.70e-04 | 18 | 47 | 2 | 20180986 | |
| Pubmed | NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. | 2.70e-04 | 18 | 47 | 2 | 19470168 | |
| Pubmed | 2.70e-04 | 18 | 47 | 2 | 31412026 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 3.01e-04 | 19 | 47 | 2 | 30228200 | |
| Pubmed | Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. | 3.01e-04 | 19 | 47 | 2 | 20554694 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 6.47e-04 | 516 | 47 | 5 | 36610398 | |
| Pubmed | 7.67e-04 | 132 | 47 | 3 | 26439863 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.85e-04 | 1489 | 47 | 8 | 28611215 | |
| Pubmed | The unfolded protein response: integrating stress signals through the stress sensor IRE1α. | 8.11e-04 | 31 | 47 | 2 | 22013210 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 8.46e-04 | 313 | 47 | 4 | 38270169 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 8.91e-04 | 139 | 47 | 3 | 25476789 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.08e-03 | 1201 | 47 | 7 | 35696571 | |
| Pubmed | 1.16e-03 | 1215 | 47 | 7 | 15146197 | ||
| Pubmed | 1.19e-03 | 591 | 47 | 5 | 15231748 | ||
| Interaction | OMG interactions | 2.37e-06 | 13 | 42 | 3 | int:OMG | |
| Interaction | PPFIA3 interactions | 5.94e-06 | 57 | 42 | 4 | int:PPFIA3 | |
| Interaction | PPFIA2 interactions | 6.22e-05 | 37 | 42 | 3 | int:PPFIA2 | |
| Interaction | SLITRK1 interactions | 6.33e-05 | 6 | 42 | 2 | int:SLITRK1 | |
| Interaction | CNR2 interactions | 8.02e-05 | 110 | 42 | 4 | int:CNR2 | |
| Interaction | IL1RAP interactions | 1.05e-04 | 44 | 42 | 3 | int:IL1RAP | |
| Cytoband | 9q31.1 | 1.04e-05 | 41 | 47 | 3 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 3.83e-04 | 137 | 47 | 3 | chr9q31 | |
| Cytoband | 9p13.3 | 2.71e-03 | 75 | 47 | 2 | 9p13.3 | |
| Cytoband | 7q11.23 | 4.49e-03 | 97 | 47 | 2 | 7q11.23 | |
| GeneFamily | Olfactory receptors, family 13 | 5.68e-10 | 23 | 34 | 5 | 162 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.90e-06 | 21 | 34 | 3 | 813 | |
| GeneFamily | Protein tyrosine phosphatases type IVA | 1.03e-05 | 3 | 34 | 2 | 899 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.28e-04 | 161 | 34 | 4 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 3.33e-03 | 160 | 34 | 3 | 555 | |
| Coexpression | MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN | 1.24e-06 | 207 | 44 | 6 | M38977 | |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 1.96e-06 | 224 | 44 | 6 | M38981 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP | 2.10e-05 | 200 | 44 | 5 | M318 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 186 | 45 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 45 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 45 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 45 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 45 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.37e-05 | 166 | 45 | 4 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 2.72e-05 | 172 | 45 | 4 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 3.11e-05 | 178 | 45 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | PBMC-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 3.11e-05 | 178 | 45 | 4 | 0667abc05eb2254710b9c648c65b7cfdfe7831b7 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 179 | 45 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 180 | 45 | 4 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-05 | 180 | 45 | 4 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 45 | 4 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 3.39e-05 | 182 | 45 | 4 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 182 | 45 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.46e-05 | 183 | 45 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.54e-05 | 184 | 45 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.61e-05 | 185 | 45 | 4 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 187 | 45 | 4 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.77e-05 | 187 | 45 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-05 | 188 | 45 | 4 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.93e-05 | 189 | 45 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 189 | 45 | 4 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.01e-05 | 190 | 45 | 4 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-05 | 191 | 45 | 4 | faf4de97003a938a243b0101456913c2b0e1804f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-05 | 192 | 45 | 4 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 193 | 45 | 4 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 193 | 45 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 193 | 45 | 4 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 193 | 45 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 193 | 45 | 4 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 193 | 45 | 4 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-05 | 194 | 45 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 195 | 45 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 195 | 45 | 4 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 195 | 45 | 4 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 197 | 45 | 4 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 197 | 45 | 4 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.62e-05 | 197 | 45 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.71e-05 | 198 | 45 | 4 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 198 | 45 | 4 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Biopsy_Control_(H.)|World / Sample group, Lineage and Cell type | 4.80e-05 | 199 | 45 | 4 | 254c255292d9810fcea017526eae5ddb3a465ce3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 3.42e-04 | 135 | 45 | 3 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 151 | 45 | 3 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-04 | 151 | 45 | 3 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-04 | 154 | 45 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-04 | 154 | 45 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-04 | 155 | 45 | 3 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-04 | 155 | 45 | 3 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage-Microglia_Siglech|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 155 | 45 | 3 | f59ca572556c17c606604da1b0331710d4751e54 | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.21e-04 | 156 | 45 | 3 | 4b6b59a1638a7218a9ed9bd702c04d9f51dbc7aa | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.21e-04 | 156 | 45 | 3 | 60a8a8584d3c80c4ceb433cb820de914e33e3500 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.61e-04 | 160 | 45 | 3 | 8374ae912337947b2cc8d17d5840f306361fe1ff | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-Microglia_Siglech|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.61e-04 | 160 | 45 | 3 | c3f2f362e5d0602bb997e8367b4c9a8fe88e4ea8 | |
| ToppCell | Control-Treg|World / Disease group and Cell class | 5.72e-04 | 161 | 45 | 3 | ead9f5a491321f9e307f7c97e47a4ca124f59bb6 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.92e-04 | 163 | 45 | 3 | ae9c5eb19657ea94b7f2357cbc8679acd697b8fe | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.92e-04 | 163 | 45 | 3 | b89f586b444f90047c8ce407f53847fd1ee7cca3 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-04 | 163 | 45 | 3 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.92e-04 | 163 | 45 | 3 | cbe9b4c4b2e42e9f92a57ed66758af93434db5bb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-04 | 164 | 45 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-04 | 164 | 45 | 3 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 165 | 45 | 3 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 6.25e-04 | 166 | 45 | 3 | ba42349a68b22e91a0340bda1ccecd6c7592392f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 6.25e-04 | 166 | 45 | 3 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 6.25e-04 | 166 | 45 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-04 | 167 | 45 | 3 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | (3)_MNP-(3)_DC_plasmacytoid|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.47e-04 | 168 | 45 | 3 | 13c160ea1a19b47d2e7e2dae818c8dcde4e3e377 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.69e-04 | 170 | 45 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-04 | 170 | 45 | 3 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-04 | 170 | 45 | 3 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.81e-04 | 171 | 45 | 3 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.81e-04 | 171 | 45 | 3 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.81e-04 | 171 | 45 | 3 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-04 | 172 | 45 | 3 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | NS-critical-d_0-4-Epithelial-FOXN4+|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.92e-04 | 172 | 45 | 3 | a00bb44d33658cb3a98accd6b60f3ce964c425b4 | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.04e-04 | 173 | 45 | 3 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-04 | 173 | 45 | 3 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.04e-04 | 173 | 45 | 3 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 173 | 45 | 3 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 173 | 45 | 3 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.16e-04 | 174 | 45 | 3 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 174 | 45 | 3 | 8d6df5938cef542f23259ce471eea1a1afbed03c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 174 | 45 | 3 | 2af54c3427aacfa232e2aca6003b4a8ecb8bba66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 174 | 45 | 3 | eca643b8f5b92aeed5a77c94b4301fd8100f9401 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.28e-04 | 175 | 45 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-04 | 175 | 45 | 3 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| Disease | azoospermia (implicated_via_orthology) | 8.23e-06 | 27 | 43 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Disproportionate short stature | 1.96e-04 | 77 | 43 | 3 | C0878659 | |
| Disease | sarcopenia | 3.88e-04 | 20 | 43 | 2 | EFO_1000653 | |
| Disease | blood viscosity | 9.39e-04 | 31 | 43 | 2 | EFO_0004301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVTKEMEPYMPLYTR | 441 | Q75V66 | |
| KYPCEYVMVQDMLSP | 1046 | Q9NZJ5 | |
| IPVDMKDNYYKTPLM | 516 | Q9NU02 | |
| KARYQTITILPMEMY | 331 | Q5VWQ8 | |
| LRYPVVMSKAAYMPI | 131 | Q8NH95 | |
| LRYPVVMSKAAYMPK | 131 | P0DN81 | |
| SREDLMKMVRPPYSY | 136 | A8MTJ6 | |
| YASMDVKYPPVIVEM | 231 | P20916 | |
| RLPMMLQEQYAYEKP | 3856 | Q15751 | |
| MDMPRGNKYEVKVYT | 166 | Q8IVV2 | |
| MPAVKAIIYQYMEEI | 331 | P37268 | |
| KYPVMIQRASYMPPK | 396 | Q7L5Y1 | |
| CQETPEGYKVMYTPM | 2431 | O75369 | |
| NMKVSRPVMEKVPYA | 1161 | Q6ZNL6 | |
| TPRMSPDFTVYMIKY | 511 | Q14332 | |
| RYPIIMSKDAYVPMA | 131 | Q8NGS8 | |
| RYPIIMSKDAYVPMA | 131 | Q8NGS9 | |
| VVDPMAEYNMPQYIL | 1806 | Q13332 | |
| DVLYPYFMVQKEMVP | 211 | A1L0T0 | |
| MKLYPVVYEESMNTV | 3861 | Q8TD57 | |
| YKSMQPEMDRVIEFY | 516 | Q8IY82 | |
| EEGMMINISIVYRYP | 36 | Q9HDB8 | |
| YPMVYPMKITGNRAV | 131 | Q8N6U8 | |
| MAVVSKMPFVPTNYY | 386 | P48728 | |
| TVMVPVPYEKMLRDQ | 126 | Q86UP8 | |
| TVMVPVPYEKMLRDQ | 126 | Q6EKJ0 | |
| VDPMAEYNMPQYILR | 1766 | P10586 | |
| VDPMAEYNMPQYILR | 1771 | P23468 | |
| RYPIIMSKNAYVPMA | 131 | Q8NGT0 | |
| MYPVRNYSPTEMVCI | 351 | Q14242 | |
| DNMLYMVIVPIVPDY | 46 | Q16572 | |
| MTKSDLQPPNYYEVM | 431 | O75674 | |
| PFYDAKRAMQIIEMY | 261 | Q15147 | |
| MVVKSVELMSVYQYP | 356 | Q969F9 | |
| KVYDQMPEPRYVVSM | 136 | O75251 | |
| DRIYYMVAPSPEAMR | 1221 | Q86SQ0 | |
| YNYIRIMVMENVNKP | 686 | Q9Y5Q9 | |
| MPYFIQVMREYLSKV | 1596 | P53675 | |
| RYTIMVDKYIPNISM | 971 | P42695 | |
| YVNDRPTNDMRYPMK | 291 | O95455 | |
| PYLDMVIAETLRMYP | 391 | P24557 | |
| MARMNRPAPVEVSYK | 1 | O75365 | |
| YLITYQIMRPEGMVD | 1151 | Q9H2K2 | |
| KVYRKDPYPEEMMRQ | 1001 | Q07157 | |
| KDIYYKIRCVLMPMP | 86 | Q9BSR8 | |
| NEMVIMRPGNKYEYK | 86 | Q9H3M7 | |
| MARMNRPAPVEVTYK | 1 | Q93096 |